Hamid Ghanadan - LINUS
7.6K posts

Hamid Ghanadan - LINUS
@HamidGhanadan
Founder of The Linus Group: helping science and healthcare executives make transformative decisions. Author Persuading Scientists and Catalytic Experiences.




Humbling 30 year Biotech stats shared by @verdadcap in a recent report: Just over 1,000 biotechs hit $200M mkt cap at some point. Of those, 67% have lost value (had cumulative negative returns), vs 48% for all other US companies. Of these 600+ biotechs, roughly 50% were acquired at negative total returns, 10% delisted, the remaining 40% are still public and underwater for their average investor The median biotech company in this period has delivered an annualized return of -15% (vs 1% for other US Companies). It's a tough business.



Frameless exhibition London ‘The storm on the Sea of Galilee’








Population density in Europe. Spain is shockingly empty






No skips allowed; repost a perfect 10/10 album, in your opinion.
















